ADC Therapeutics SA Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019
ADC Therapeutics SA (ADCT) had Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019 of $18.77 per share as of 2022-12-31, per its 20-F filed 2023-03-15.
Discontinued › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 · last filed 2023-03-15
- 2022-12-31: Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019 $18.77.
- 2020-12-31: Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019 $24.87.
- 2019-12-31: Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019 $18.75.
| Period end | Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019 |
|---|---|
| 2022-12-31 | $18.77 20-F · filed 2023-03-15 |
| 2020-12-31 | $24.87 20-F · filed 2022-03-17 |
| 2019-12-31 | $18.75 20-F · filed 2021-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |